Latent Autoimmune Diabetes in Adults: A Case Report
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Abstract
Latent autoimmune diabetes in adults (LADA) is a slow progressive autoimmune destruction of pancreatic beta cells. This condition tends to manifest during adulthood, often around 35 years of age. While LADA can initially be managed by oral medications, eventually the patient will require insulin. We report a case of a 34-year-old woman who was initially treated for type 2 diabetes mellitus but was later diagnosed with LADA.
References
1.
Pozzilli P, Pieralice S
. Latent Autoimmune Diabetes in Adults: Current Status and New Horizons. Endocrinol Metab (Seoul). 2018; 33(2):147-159.
PMC: 6021307.
DOI: 10.3803/EnM.2018.33.2.147.
View
2.
Myhill P, Davis W, Bruce D, Mackay I, Zimmet P, Davis T
. Chronic complications and mortality in community-based patients with latent autoimmune diabetes in adults: the Fremantle Diabetes Study. Diabet Med. 2008; 25(10):1245-50.
DOI: 10.1111/j.1464-5491.2008.02562.x.
View
3.
Poudel R
. Latent autoimmune diabetes of adults: From oral hypoglycemic agents to early insulin. Indian J Endocrinol Metab. 2012; 16 Suppl 1:S41-6.
PMC: 3354922.
DOI: 10.4103/2230-8210.94257.
View
4.
Kietsiriroje N, Pearson S, Campbell M, Ariens R, Ajjan R
. Double diabetes: A distinct high-risk group?. Diabetes Obes Metab. 2019; 21(12):2609-2618.
DOI: 10.1111/dom.13848.
View
5.
Lutgens M, Meijer M, Peeters B, Poulsen M, Rutten M, Bots M
. Easily obtainable clinical features increase the diagnostic accuracy for latent autoimmune diabetes in adults: an evidence-based report. Prim Care Diabetes. 2008; 2(4):207-11.
DOI: 10.1016/j.pcd.2008.08.003.
View